Back
RenovoRx, Inc. 10K Form
Sell
43
RNXT
RenovoRx, Inc.
Last Price:
$0.95
Seasonality Move:
66.77%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RNXT News And Ratings
See the #1 stock for the next 7 days that we like better than RNXT
RNXT Financial Statistics
Sales & Book Value
| Annual Sales: | $43K |
|---|---|
| Cash Flow: | $-2.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.22 |
| Price / Book: | 4.27 |
Profitability
| EPS (TTM): | -0.35550 |
|---|---|
| Net Income (TTM): | $-11.1M |
| Gross Margin: | $0 |
| Return on Equity: | -127.86% |
| Return on Assets: | -93.97% |
RenovoRx, Inc. Earnings Forecast
Key RenovoRx, Inc. Financial Ratios
-
The Gross Profit Margin over the past 6 years for RNXT is 0.00%.
-
The Selling, General & Administrative Expenses for RNXT have been equal to 11,600.00% of Gross Profit Margin.
-
The Research & Development expenses have been 14,011.63% of Revenue.
-
The Net Earning history of RNXT is -20,497.67% of Total Revenues.
-
Per Share Earnings over the last 6 years have been positive in 3 years.
RenovoRx, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | RNXT |
| Website: | renovorx.com |
Debt
| Debt-to-Equity Ratio: | 0.03 |
|---|---|
| Current Ratio: | 5.83 |
| Quick Ratio: | 5.42 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
RNXT Technical Analysis vs Fundamental Analysis
Sell
43
RenovoRx, Inc. (RNXT)
is a Sell
Is RenovoRx, Inc. a Buy or a Sell?
-
RenovoRx, Inc. stock is rated a SellThe current RenovoRx, Inc. [RNXT] share price is $0.94. The Score for RNXT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.